Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More
Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More
Psyched：史蒂夫·科恩的新生物制药赌注，加利福尼亚州州长授权医用迷幻药等
Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares
史蒂夫·科恩继续押注生物制药，购买了1.19亿多股生物经济学股票
NY Mets owner Steve Cohen has bought as many as 119,092,680 ordinary shares of clinical-stage biopharmaceutical company Bionomics Limited (NASDAQ:BNOX) through his Point72 asset management firm, again showing support for the biopharma sector (See recent buy of Cybin (NYSE: CYBN) shares.)
纽约大都会队老板史蒂夫·科恩通过其Point72资产管理公司购买了临床阶段的生物制药公司Bionomics Limited（纳斯达克股票代码：BNOX）的多达119,092,680股普通股，再次表示对生物制药行业的支持（见最近对Cybin（纽约证券交易所代码：CYBN）股票的买入。）
The Australia-based company currently trades on the Nasdaq and in the Frankfurt Stock Exchange (Fra) by means of American Depositary Shares (ADS) and recently announced its delisting intentions from the Australian Securities Exchange (ASX) following a U.S.-focused transformation plan. Read more HERE.
这家总部位于澳大利亚的公司目前通过美国存托股票（ADS）在纳斯达克和法兰克福证券交易所（Fra）上市，并根据一项以美国为重点的转型计划，最近宣布打算从澳大利亚证券交易所（ASX）退市。点击此处阅读更多。
Gov Newsom Green...
州长 ...
登录免费看全文
登录/注册
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。